CYCLERION THERAPEUTICS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
CYCLERION THERAPEUTICS, INC. (CYCN) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $26.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-04
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$889.00K.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $915.00K, a 656.20% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$157.00K.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $85.00K.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was -$1.58M.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2022 was -$522.00K.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2021 was -$4.33M.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2020 was -$1.98M.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$889.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | $26.00K 10-Q · filed 2026-08-04 | -$131.00K derived: sum of 3 quarters · filed 2026-08-04 | -$46.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $915.00K S-4/A · filed 2026-07-22 | $758.00K derived: sum of 2 quarters · filed 2026-07-22 | $843.00K derived: sum of 3 quarters · filed 2026-07-22 | $705.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$157.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | -$72.00K derived: sum of 2 quarters · filed 2026-07-22 | -$210.00K derived: sum of 3 quarters · filed 2026-08-04 | -$89.00K S-4/A · filed 2026-07-22 |
| 2025-09-30 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$53.00K derived: sum of 2 quarters · filed 2026-08-04 | $68.00K 10-Q · filed 2025-11-12 | $27.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$138.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | -$17.00K 10-Q · filed 2026-08-04 | -$58.00K derived: sum of 3 quarters · filed 2026-08-04 | -$268.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $121.00K S-4/A · filed 2026-07-22 | $80.00K derived: sum of 2 quarters · filed 2026-07-22 | -$130.00K derived: sum of 3 quarters · filed 2026-07-22 | -$206.00K derived: sum of 4 quarters · filed 2026-07-22 |
| 2024-12-31 | -$41.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | -$251.00K derived: sum of 2 quarters · filed 2026-07-22 | -$327.00K derived: sum of 3 quarters · filed 2026-07-22 | -$515.00K S-4/A · filed 2026-07-22 |
| 2024-09-30 | -$210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$286.00K derived: sum of 2 quarters · filed 2025-11-12 | -$474.00K 10-Q · filed 2025-11-12 | -$841.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$264.00K 10-Q · filed 2025-08-05 | -$631.00K derived: sum of 3 quarters · filed 2025-11-12 | -$1.93M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-03-31 | -$188.00K 10-Q · filed 2025-05-06 | -$555.00K derived: sum of 2 quarters · filed 2025-11-12 | -$1.85M derived: sum of 3 quarters · filed 2025-11-12 | -$1.39M derived: sum of 4 quarters · filed 2025-11-12 |
| 2023-12-31 | -$367.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | -$1.67M derived: sum of 2 quarters · filed 2025-11-12 | -$1.20M derived: sum of 3 quarters · filed 2025-11-12 | -$1.58M 10-K/A · filed 2025-11-12 |
| 2023-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$836.00K derived: sum of 2 quarters · filed 2024-11-14 | -$1.22M 10-Q · filed 2024-11-14 | -$1.40M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $462.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $81.00K 10-Q · filed 2024-08-07 | -$105.00K derived: sum of 3 quarters · filed 2024-08-07 | $137.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$381.00K 10-Q · filed 2024-05-07 | -$567.00K derived: sum of 2 quarters · filed 2024-05-07 | -$325.00K derived: sum of 3 quarters · filed 2024-05-07 | -$433.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $56.00K derived: sum of 2 quarters · filed 2024-03-05 | -$52.00K derived: sum of 3 quarters · filed 2024-03-05 | -$522.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $242.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $134.00K derived: sum of 2 quarters · filed 2023-11-13 | -$336.00K 10-Q · filed 2023-11-13 | -$617.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | -$578.00K 10-Q · filed 2023-07-28 | -$859.00K derived: sum of 3 quarters · filed 2023-07-28 | -$994.00K derived: sum of 4 quarters · filed 2023-07-28 |
| 2022-03-31 | -$470.00K 10-Q · filed 2023-05-12 | -$751.00K derived: sum of 2 quarters · filed 2023-05-12 | -$886.00K derived: sum of 3 quarters · filed 2023-05-12 | -$1.37M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$416.00K derived: sum of 2 quarters · filed 2023-03-22 | -$900.00K derived: sum of 3 quarters · filed 2023-03-22 | -$4.33M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$619.00K derived: sum of 2 quarters · filed 2022-11-03 | -$4.05M 10-Q · filed 2022-11-03 | -$2.36M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$484.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$3.92M 10-Q · filed 2022-08-09 | -$2.23M derived: sum of 3 quarters · filed 2022-08-09 | -$1.74M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$3.44M 10-Q · filed 2022-05-04 | -$1.75M derived: sum of 2 quarters · filed 2022-05-04 | -$1.25M derived: sum of 3 quarters · filed 2022-05-04 | -$705.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.18M derived: sum of 2 quarters · filed 2022-02-24 | $2.73M derived: sum of 3 quarters · filed 2022-02-24 | -$1.98M 10-K · filed 2022-02-24 |
| 2020-09-30 | $493.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.04M derived: sum of 2 quarters · filed 2021-11-09 | -$3.67M 10-Q · filed 2021-11-09 | -$1.69M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $547.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$4.17M 10-Q · filed 2021-07-29 | -$2.19M derived: sum of 3 quarters · filed 2021-07-29 | -$1.91M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | -$4.71M 10-Q · filed 2021-04-30 | -$2.73M derived: sum of 2 quarters · filed 2021-04-30 | -$2.45M derived: sum of 3 quarters · filed 2021-04-30 | -$995.00K derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.26M derived: sum of 2 quarters · filed 2021-02-25 | $3.72M derived: sum of 3 quarters · filed 2021-02-25 | -$1.56M 10-K · filed 2021-02-25 |
| 2019-09-30 | $281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.74M derived: sum of 2 quarters · filed 2020-11-05 | -$3.54M 10-Q · filed 2020-11-05 | -$1.04M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | -$3.82M 10-Q · filed 2020-08-03 | -$1.32M derived: sum of 3 quarters · filed 2020-08-03 | -$2.18M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | -$5.27M 10-Q · filed 2020-05-04 | -$2.78M derived: sum of 2 quarters · filed 2020-05-04 | -$3.64M derived: sum of 3 quarters · filed 2020-05-04 | |
| 2018-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.63M derived: sum of 2 quarters · filed 2020-03-12 | $2.02M 10-K · filed 2020-03-12 | |
| 2018-09-30 | -$857.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$473.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $384.00K 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |